Status:
COMPLETED
Long-term Study to Evaluate Different Dental Implant Alloys in Straumann 3.3mm Diameter Bone Level Implants
Lead Sponsor:
Institut Straumann AG
Conditions:
Jaw, Edentulous
Eligibility:
All Genders
18+ years
Brief Summary
Patients with an edentulous mandible restored with implants who have participated in the core study CR 04/07 will be recruited for this extension study. No further interventions will be made for this ...
Detailed Description
The primary study objective is to compare implant survival with the Titanium Zirconium (Roxolid™) implant compared the Titanium grade IV (SLActive®) implant between baseline (surgery) and 10 years. T...
Eligibility Criteria
Inclusion
- Subjects must have voluntarily signed the informed consent form
- Patients must be committed to participate in the study until the ten year follow-up examinations
- Subjects must have received treatment in the CR 04/07 core study
- Subjects must have completed 3 year visit of core study
Exclusion
- Physical handicaps that would interfere with the ability to perform adequate oral hygiene or attend follow up visits
- Use of any investigational drug or device during the study
- Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance, unreliability
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2018
Estimated Enrollment :
49 Patients enrolled
Trial Details
Trial ID
NCT01878331
Start Date
June 1 2013
End Date
September 1 2018
Last Update
January 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Frauke Müller
Geneva, Switzerland, 1211